Alice Lin is the Senior Director of Analytical Sciences at AstraZeneca, where they lead initiatives in Cell Therapy Development and Operations. With over 10 years of experience in assay development and quality control within GxP environments, Alice has played pivotal roles in supporting IND and BLA filings for innovative cell therapy products. Their previous positions include leadership roles at Kite Pharma and Fate Therapeutics, where they successfully managed quality control teams and expanded testing capacities. Alice holds a Ph.D. in Biochemistry and Molecular Biology from the University of California, Riverside, and has contributed to numerous analytical methods and product launches throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices